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Abstract 
Purpose: Less than 10% of heart failure patients in the UK participate in cardiac rehabilitation 
programmes. The present pilot study evaluated feasibility, acceptability and physiological 
effects of a novel, personalised, home-based physical activity intervention in chronic heart 
failure.  
Methods: Twenty patients (68±7 years old, 20% females) with stable chronic heart failure due 
to reduced left ventricular ejection fraction (31±8 %) participated in a single group, pilot study 
assessing the feasibility and acceptability of a 12-week personalised home-based physical 
activity intervention aiming to increase daily number of steps by 2000 from baseline (Active-
at-Home-HF). Patients completed cardiopulmonary exercise testing with non-invasive gas 
exchange and haemodynamic measurements and quality of life questionnaire pre- and post-
intervention. Patients were supported weekly via telephone and average weekly step count data 
collected using pedometers. 
Results: 43 patients were screened and 20 recruited into the study. Seventeen patients (85%) 
completed the intervention, and 15 (75%) achieved the target step count. Average step count 
per day increased significantly from baseline to 3 weeks by 2546 (5108±3064 to 7654±3849 
P=0.03, n=17), and was maintained until week 12 (9022±3942). Following completion of the 
intervention, no adverse events were recorded, quality of life improved by 4 points (26±18 vs. 
22±19). Peak exercise stroke volume increased by 19% (127±34 vs 151±34 m/beat, P=0.05), 
while cardiac index increased by 12% (6.8±1.5 vs. 7.6±2.0 L/min/m2, P=0.19). Workload and 
oxygen consumption at anaerobic threshold also increased by 16% (49±16 vs. 59±14 watts, 
P=0.01) and 10% (11.5±2.9 vs. 12.8±2.2 ml/kg/min, P=0.39) 
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Conclusion: The Active-at-Home-HF intervention is feasible, acceptable and effective for 
increasing physical activity in CHF. It may lead to improvements in quality of life, exercise 
tolerance and haemodynamic function. 
Keywords: Physical Activity, Chronic Heart failure, Home-based intervention, Behavioural 
Change 
Key Points: 
x A personalized, home-based physical activity intervention is acceptable, feasible and 
could lead to improvement in exercise tolerance and quality of life in chronic heart 
failure patients.  
x Increasing step count by at least 2000 steps per day may be a realistic goal for chronic 
heart failure patients. 
Trial Registration: www.clinicaltrials.gov - NCT0367727. Retrospectively registered on 17th 
September 2018. 
Background 
The benefits of cardiac rehabilitation in chronic heart failure (CHF) have been well documented 
(1). Evidence-based clinical guidelines recommend that physical activity is integrated into 
cardiac rehabilitation as a cornerstone of clinical management of CHF (2). Meta-analyses have 
demonstrated that increased physical activity can improve functional capacity, quality of life, 
reduce symptom burden, likelihood of hospitalisation and can improve cardiac function (3,4). 
Consequently, current guidelines now emphasize physical activity as an important component 
of cardiac rehabilitation in addition to patient education, psychological support and drug 
therapy (2,5,6). 
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Despite numerous benefits, participation of heart failure patients in cardiac rehabilitation is 
low. In the United Kingdom (UK), less than 10% of patients with CHF participate in cardiac 
rehabilitation (7). Potential explanations include exclusion of cardiac rehabilitation 
programmes from local commissioning agreements due to limited funds, lack of capacity for 
supervised programmes, and inadequate social support for patients (8). Other patient factors 
include unwillingness to participate in cardiac rehabilitation due to difficulties in attending 
hospitals, work or domestic commitments and reluctance to attend group-based classes (9). 
The barriers highlighted above could be potentially overcome by promoting increased physical 
activity at home. Daily habitual physical activity (i.e. number of steps and active energy 
expenditure) is inversely related to patients’ symptoms (10). Walking is an independent 
predictor of outcomes in patients with advanced CHF (11). Current physical activity 
recommendations for adults is 150 to 300 minutes per week of moderate-intensity activity, or 
75 minutes to 150 minutes per week of vigorous-intensity aerobic physical activity, or an 
equivalent combination of moderate- and vigorous-intensity aerobic activity while 
incorporating muscle-strengthening activities if tolerated (6). For adults who are unable to meet 
these guidelines due to chronic conditions or disabilities, regular physical activity according to 
their ability is recommended (6). As such, it may be challenging to identify a standardised daily 
physical activity routine appropriate for all heart failure patients’ accounting for individual 
differences. Pedometer based interventions have demonstrated that increasing steps per day by 
approximately 2000-2500 steps leads to improvements in blood pressure (12,13) and insulin 
sensitivity (14). Furthermore, a large cohort study involving 9306 participants reported a 10% 
risk reduction of cardiovascular events in individuals at high risk of developing type 2 diabetes 
for every 2000 steps/day increment in daily physical activity observed (15). Considering these 
findings, we developed a novel, personalised, home-based (Active-at-Home-HF) physical 
activity intervention aiming to increase daily physical activity by 2000 steps in patients with 
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CHF. The aim of the present pilot study was to assess feasibility, acceptability and preliminary 
efficacy of the Active-at-Home-HF intervention. 
Methods 
Study design 
A single group, pilot study assessed the feasibility, acceptability and preliminary efficacy of a 
home-based physical activity intervention in adults with CHF with reduced left ventricular 
ejection fraction. Eligible participants attended the Clinical Research Facility of the Royal 
Victoria Infirmary, Newcastle-upon-Tyne UK for two separate visits (i.e. before and after the 
12-week intervention). Participants were contacted via email, telephone or spoken to in person 
to discuss the study and given an opportunity to ask questions to ensure they understood the 
procedure.  
Participants 
Potentially eligible patients were identified by cardiologists via medical records from heart 
failure clinics at the Royal Victoria Infirmary and Freeman Hospital in Newcastle-upon-Tyne. 
These patients were subsequently screened by the same cardiologists using the study eligibility 
criteria. Once eligibility was confirmed, patients were recruited by a member of the research 
team (NO, SC) by telephone contact. The study included patients with a left ventricular ejection 
fraction ≤ 40%, diagnosed for at least three months, classified according to the New York Heart 
Association (NYHA) class II – III, clinically stable and receiving an optimal medical treatment. 
Patients were required to have no contraindications to physical activity and had to be capable 
of performing activities of daily living independently. Patients were excluded during screening 
or contact if they had uncontrolled cardiac arrhythmias, myocardial infarction, percutaneous 
coronary intervention and/or bypass graft surgery up to 3 months previously, severe obesity 
(i.e. body mass index >40), implantation with left ventricular assist device, were currently 
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participating in a cardiac rehabilitation programme, if they already met physical activity 
recommendations (6) or were unable to provide informed written consent.  
Clinical assessments 
During baseline and 12-week follow-up visits, patients underwent clinical assessments 
including quality of life using the Minnesota Living with Heart Failure questionnaire, blood 
sampling for N-Terminal pro b-type Natriuretic Peptide (NTproBNP), cardiopulmonary 
pulmonary exercise stress testing on a semi-recumbent cycle ergometer (Corival, Lode & 
Groningen, Netherlands) coupled with non-invasive haemodynamic monitoring (NICOM®, 
Cheetah Medical, Delaware, USA). A graded exercise test protocol was used for 
cardiopulmonary exercise testing. This involved maintaining a pedal frequency of 60-70 
revolutions per minute with workload increasing at the rate of 10 watts per minute. The test 
was terminated when maximal exertion was achieved, or when the patient was unable to 
maintain the required cycling cadence, or if the patient desired to stop. Physical activity (step 
count) was measured continuously using a pedometer (Omron Health care, Model no: HJ-321-
E, Japan). Patients recorded daily step counts at the end of each day using a paper-based activity 
tracker and results were communicated weekly to a member of the study team. 
The home-based physical activity programme (Active-at-Home-HF) 
The Active-at-Home-HF intervention was designed for patients with CHF to encourage an 
increase in their overall daily physical activity levels by at least 2000 steps per day from 
baseline. This behavioural intervention was delivered by telephone to participants in the north-
east of England who were patients at the Royal Victoria Infirmary or Freeman Hospital, 
Newcastle upon Tyne. The intervention team comprised of Cardiologists, Exercise 
physiologists and health psychologists. Team members (NCO and SC) involved in monitoring 
patients were experienced clinical exercise physiologists certified by the American College of 
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Sports Medicine. They also received training delivered by a Chartered health psychologist with 
expertise in health behaviour change (LA) who was also a member of the research team, on the 
delivery/use of evidence-based behaviour change techniques selected to target physical activity 
behaviour (e.g., physical activity goal setting, problem solving, self-monitoring) (16,17)  . The 
same health psychologist developed the brief behavioural intervention, intended for delivery 
by telephone using a proforma to prompt use of the specific behaviour change techniques. This 
proforma also served as a record for future discussions following completion during each 
intervention session delivered. The intervention differed from centre-based programmes in that 
it focussed on free-living physical activity, did not rely on exercise equipment, was delivered 
by weekly telephone sessions, and focussed on providing participants with the knowledge and 
behavioural skills to increase and maintain physical activity levels despite the barriers they 
might face. Once patients enrolled in to the study, they were supported by weekly telephone 
calls lasting approximately 10 minutes in duration, designed to initiate, increase and maintain 
their activity levels. This was achieved through behavioural goal setting where the patient 
would set a physical activity goal with the guidance and support of a trained research team 
member. Barriers to reaching the goal were discussed followed by mutual identification of 
solutions to overcome those barriers. Patients were encouraged to consider times in the past 
where they had been more physically active as a means of increasing confidence and 
motivation. Self-monitoring was used to encourage maintenance of activity levels and patients 
were prompted to involve family members and friends in their attempts to increase physical 
activity levels as a means of social support. At the end of each day, the goal was to achieve at 
least 2000 steps more than the average daily number of steps obtained at baseline as indicated 
on the pedometer. Physical activity levels were adjusted on an individual basis as conditioning 
took place, with the emphasis on volume of activity i.e. duration and number of steps rather 
than intensity.  
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Outcomes 
The primary outcomes of interest were acceptability and feasibility of the intervention. 
Secondary outcomes were changes in functional capacity assessed by peak exercise oxygen 
consumption and power output, quality of life, haemodynamic function and changes in 
NTproBNP. Feasibility was defined as willingness of patients to enrol on to the Active-at-
Home-HF intervention and was confirmed by recruiting the targeted number of patients. The 
recruitment target deadline was set at nine months after recruiting first patient. Acceptability 
was defined as willingness to engage with and adhere to the intervention and was reported as 
the percentage of patients who completed intervention. The intervention was considered 
acceptable if ≥ 80% of patients completed it. This included weekly engagement by telephone 
and completion of daily physical activity records. If engagement with each of these components 
was recorded, the intervention was considered acceptable.  
Statistical analysis 
The primary aim of the present study was to assess acceptability and feasibility of the 
intervention. It is generally accepted that pilot feasibility studies do not require a formal power 
calculation (18). However, it was important to assess whether the Active-at-Home-HF 
intervention, if acceptable and feasible, was capable of improving outcomes of interest to allow 
a judgement to be made as to whether the intervention is comparable to a centre-based 
intervention. It was therefore estimated that a sample size of 20 patients would provide 
sufficient power to detect a clinically acceptable change/increase in peak oxygen consumption 
of 3 ml/min/kg  post intervention, at the significance level of 5% (β=0.82, α=0.05). The 
relationship between physical activity and physiological variables was assessed using 
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Pearson’s coefficient of correlation. Statistical significance was indicated if P<0.05. All 
statistical analyses were carried out using SPSS version 24.0 (SPSS, Chicago, IL, USA). 
Results  
Acceptability and Feasibility 
Out of 43 CHF patients contacted by telephone after initials screening, 20 patients met the 
study inclusion criteria and were willing to take part and were subsequently recruited. 
Recruitment took place between December 2015 and September 2016. Patients were excluded 
(n=23) if they already met recommended physical activity guidelines (5)(n=4), were too ill to 
participate (NYHA stage IV) or recent hospitalisation (n=8). Patients were also excluded if 
they refused to participate for personal reasons (n=4), time commitment (n=3), ‘feeling not be 
able to due to age’ (n=1), or too nervous to participate in a physical activity intervention (n=3). 
Recruited patients’ demographic and clinical characteristics are presented in Table 1. No 
adverse events occurred as a result of participating in the intervention/study. Seventeen 
participants completed the 12-week physical activity intervention. However, two patients were 
unable to meet or sustain the required minimum target of 2000 steps above baseline due to 
severe arthritis. The intervention was considered acceptable and feasible as the required 
number of patients were recruited, and the majority of patients completed the intervention 
(completion rate 85%; n=17) (see Figure 1). 
[INSERT FIGURE 1] 
In situations where patients expressed concerns about their arrhythmias or ischaemia, they were 
further assessed by the team’s consultant cardiologist and were reassured about safety of 
participation in the intervention before they took part in the study. 
[INSERT TABLE 1] 
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The target step count goal of 2000 steps from baseline was achieved at week three with average 
number of steps per day increasing significantly by 2546 from (5108±3064 to 7654±3849 
steps/day, p=0.03), and was maintained until week 12 (8890±3713 steps/day, Figure 2). Two 
patients dropped out of the study for undisclosed reasons and one participant discontinued due 
to implantable cardiac defibrillator malfunction. 
[INSERT FIGURE 2] 
Metabolic changes 
There was no statistically significant change in exercise tolerance with peak oxygen 
consumption and peak workload increasing post intervention by 4.8% and 11% respectively. 
However, workload and oxygen consumption at submaximal exercise (i.e. anaerobic threshold) 
increased by 20% (49±16 vs 59±14 watts, P=0.01) and 11% (11.5±2.9 vs 12.8±2.2 ml/kg/min, 
P=0.39) post intervention (Table 2). 
Haemodynamic changes 
The Completion of the intervention resulted in significant improvements in peak exercise 
stroke volume (126.5±33.8 vs 150.8±33.5 ml/beat, P= 0.05) and stroke volume index (64.6±14 
vs 75.2 ±17 ml/beat/m2, P=0.04). There was also a 10-15% improvement in peak exercise 
cardiac output and cardiac index, although these were not statistically significant (Table 2).  
[INSERT TABLE2] 
Blood biomarkers and Quality of life 
There were no statistically significant changes in metabolic biomarkers following completion 
of the intervention. There was a 4 point improvement in quality of life score (Table 3). 
[INSERT TABLE 3] 
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Daily number of steps correlated positively with peak oxygen consumption post-intervention 
(r=0.58, P=0.01), but not pre-intervention (r=0.39, P=0.08). The significant correlation 
observed post intervention, although moderate, suggests that daily physical activity is 
positively associated with functional capacity (exercise tolerance) in active but not sedentary 
patients with chronic HF (Figure 3).  This suggest that increasing daily walking improves 
fitness levels in heart failure patients. 
 
[INSERT FIGURE 3] 
Discussion 
The major findings of this study are that the Active-at-Home-HF intervention demonstrated to 
be both acceptable and feasible to patients with CHF and led to modest changes in exercise 
tolerance and haemodynamics. This was shown by the number of patients (85%) who engaged 
with and completed the intervention after enrolment. This figure is comparable to adherence 
rates (>75%) reported from centre based studies (19,20). Piotrowicz et al. (20), who compared 
a homebased tele-monitored cardiac rehabilitation to centre-based rehabilitation reported 100% 
adherence in the home-based group. Seventy five percent of dropouts in the centre-based group 
of the above study were due to inadequate funds and availability of transport while 25% 
dropped out due to difficulty in matching the centre based training with their daily activities. 
These findings are important because the intervention has shown to provide a viable and 
potentially low-cost (i.e. brief behavioural intervention delivered by telephone, no reliance on 
exercise equipment provision in clinical settings) alternative to centre-based programmes for 
patients not wanting to engage in group-based rehabilitation and is a solution to overcome other 
barriers including travel constraints. 
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Patients with heart failure often experience a decline in health related quality of life. Following 
clinical presentation/diagnosis, psychological distress can limit activity and lead to a decline in 
quality of life (21). Exercise training has been reported to improve quality of life in CHF (22) 
and a reduction of 5 points or more in the Minnesota living with heart failure questionnaire is 
accepted as being clinically significant (23). The present pilot feasibility study reported a 15% 
(4 point) reduction in quality of life score (i.e. an improvement in quality of life) which is 
deemed clinically insignificant and as thus, contrast studies that have reported a significant 
improvement in quality of life following exercise intervention (24). However, a 15% 
improvement is positive in a group of participants who reported a higher than average quality 
of life score at baseline (i.e. mean values of 26 points out of a possible score of 105 points in 
the questionnaire). Cowie et al., (25) also reported no significant change in quality of life in 
CHF patients following home-based or hospital-based intervention, even though there was a 
significant improvement in exercise capacity. They further suggested that in older CHF 
patients, maintaining quality of life rather than improving it might be a realistic aim for a 
physical activity or rehabilitation programme. 
At anaerobic threshold, participants were able to tolerate significantly greater workload (17% 
increase). This finding is similar to previous studies that also reported a delay in reaching 
anaerobic threshold (26) and a significant increase in power output at anaerobic threshold (27). 
Similarly, increased daily physical activity resulted in a 19% significant increase in peak stroke 
volume. Our results suggest positive adaptation to the intervention and the improvement of 
systemic oxygen delivery. Other studies have also reported significant improvements in an 
echocardiogram  generated stroke volume as a result of long term ( >12 weeks) exercise 
training (28). The capacity to increase physical activity depends on the ability of the heart to 
generate adequate cardiac output and the ability of skeletal muscles to utilise the oxygen 
delivered (29). Therefore, this provides strong evidence for the assessment of cardiac 
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heamodynamics in response to a physical activity intervention. These findings have been 
extended by other studies which demonstrated that aerobic training also improves diastolic 
filling, myocardial contractility and left ventricular ejection fraction in individuals severe left 
ventricular systolic dysfunction (30,31). Based on the findings of the current study and 
evidence from the above-mentioned studies, it is reasonable to suggest that physical activity in 
CHF can improve cardiac contractility and stroke volume, potentially leading to reverse 
remodelling.  The present study also found that increased physical activity as recorded from 
step counts following the Active-at-Home-HF intervention had a stronger correlation with peak 
oxygen consumption compared with lower step counts (sedentary behaviour) pre intervention. 
Jehn et al., who reported a positive correlation between the times spent in light activity/exercise 
(≤ 3 METs) and improved peak oxygen consumption (11), had demonstrated this previously.  
Although the use of steps per day has been criticised for not taking into account exercise 
intensity (32), a recent study by Tudor-Locke et al., (33) has shown that linear trends for steps 
per day were statistically significant for cardio-metabolic risk factors including blood pressure 
for men, weight, waist circumference, insulin, high density lipoprotein, triglycerides and 
homeostasis model assessment-estimated insulin resistance. Even at step counts of around 70 
steps per minute, which is below the recommended 100 steps per minute suggesting moderate 
intensity (32), clinically favourable values for many of the cardio-metabolic outcomes were 
observed. The present study provides further justification for the use of steps per day 
recommendations in national physical activity guidelines (34). Furthermore, the present study 
results are of clinical importance for the management of CHF patients, particularly older adults 
as most patients have concomitant exercise-limiting co-morbidities such as neuromuscular or 
orthopaedic problems making the traditional 10,000 step target (35) or steps per minute 
unrealistic and potentially harmful. As such, it may be appropriate to encourage such patients 
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to exercise at a lower intensity than has been considered necessary to increase maximal exercise 
capacity. 
Limitations   
The following limitations should be considered in the present study. Firstly, it could be argued 
that sample size limits generalisability of findings. Of the 43 patients screened, only 20 were 
enrolled into the study meaning a recruitment rate of 46%. However, this was a pilot study with 
the primary aim of establishing acceptability and feasibility of the intervention. A further 
criticism could be that this study lacked a control group. However, the primary intention of this 
study was not to establish the effect of the intervention, instead it was to assess feasibility and 
acceptability with a view to informing a larger scale evaluation (i.e. controlled trial) should the 
intervention prove to be feasible and acceptable. Secondly, it could be argued that stroke 
volume was measured non-invasively which is not the gold standard. However, the 
reproducibility of stroke volume measurements using the NICOM have previously been 
reported (36). Lastly, only two female patients were recruited into the study limiting 
generalisability of the study findings in terms of gender. The nature of this pilot study did not 
necessitate the use of digital technologies. However, digital technologies which offer additional 
evaluation of haemodynamic function such as heart rate and blood pressure will be useful in 
future studies to improve safety of patients while engaging in physical activity, and would 
likely increase feasibility. Further evaluation of the ACTIVE-at-HOME intervention: clinical 
and cost-effectiveness is warranted in an adequately powered randomised controlled trial 
Conclusion 
The present study demonstrates that the novel, home-based physical activity intervention (i.e. 
Active-at-Home-HF) is acceptable and feasible and can provide clinical and physiological 
benefits to people living with CHF. The intervention is associated with increased habitual 
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physical activity level, functional capacity and haemodynamic response to exercise. Significant 
changes in response to the Active-at-Home-HF intervention were observed in submaximal 
exercise capacity and cardiac response to exercise. The Active-at-Home-HF intervention 
provides a viable alternative to centre-based programmes. This helps to overcome barriers 
including travel cost, and reluctance to participate in group-based activity. A larger multicentre 
study is warranted to further substantiate preliminary findings from the present study.  
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Figure 2 Mean (+SD) number of steps achieved at baseline and at the end of weeks 3 and 12 
of physical activity intervention 
Figure 3 Relationship between number of steps and peak oxygen consumption pre and post 
intervention. 
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Table 1. Mean and SD (±) patients’ demographic and clinical characteristics  
Parameter 
Age (years) 68±7 
Men/women  18/2 
Weight (kg) 84±15 
Height (cm) 1.72±0.1 
Aetiology of HF (IHD/DCM)                                             10/10 
LVEF (%) 31±8 
Medication  
ACE inhibitors 15 
Β- blockers 20 
ARBs 5 
Diuretics 13 
Anti-arrhythmic 3 
NSAIDs/Pain Killers 6 
Warfarin 
ICD/Pacemakers 
Comorbidities 
COPD 
Type 2 Diabetes 
Obesity 
Hypertension 
Depression 
Arthritis 
5 
13 
 
1 
5 
6 
20 
2 
1 
ACE, angiotensin converting enzyme; ARB, angiotensin receptor blockers; LVEF, left 
ventricular ejection fraction; NSAID, non-steroid anti-inflammatory drugs; IHD, ischaemic 
heart disease; DCM, dilated cardiomyopathy; COPD, chronic obstructive pulmonary 
disease; ICD, Implantable cardioverter defibrillator 
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Table 2. Cardio-metabolic changes (mean ± SD) following 12 weeks of Active-at-Home-HF 
intervention 
 Pre 
intervention 
Post 
intervention 
P Value % Change 
Measurements at Rest 
Oxygen Consumption (ml/kg/min) 3.8±1.0 4.1±0.8 0.36 7.9 
Respiratory Exchange Ratio 0.85±0.1 0.85±0.1 0.92 0 
Heart Rate (beats/min) 67±7 70±7 0.24 4.5 
Stroke Volume Index (ml/beat) 48±9 49±8 0.75 2.0 
Cardiac Output  (l/min) 6.1±1 6.6±1 0.14 8.2 
Systolic Blood Pressure (mmHg) 118±18 124±18 0.41 4.0 
Diastolic Blood pressure (mmHg) 74±8 76±12 0.74 2.6 
Mean Arterial Pressure (mmHg) 90±9 92±13 0.66 2.2 
Measurements at Peak Exercise 
Oxygen Consumption (ml/kg/min) 16.8±3.8 17.6±4.2 0.54 4.8 
Respiratory Exchange Ratio 1.05±0.1 1.07±0.1 0.62 1.9 
Heart Rate (beats/min) 106±19 107±16 0.92 1.0 
Stroke Volume (ml/beat) 127±34 151±34 0.05* 18.9 
Stroke Volume Index (ml/beat/m2) 64±14 75±17 0.04* 17.2 
Cardiac Output  (l/min) 13.4±4 15.3±4.9 0.19 14.2 
Cardiac Index (l/min/m2) 6.8±1.5 7.6±2.0 0.19 11.7 
Systolic Blood Pressure (mmHg) 155±30 150±30 0.62 3.2 
Diastolic Blood pressure (mmHg) 80±8 79±8 0.72 1.3 
Mean Arterial Pressure (mmHg) 103±13 102±13 0.87 1.0 
Peak exercise workload (watts) 82±10 91±19 0.21 11 
Exercise workload at anaerobic 
threshold (watts) 
49±16 59±14 0.01* 20 
Oxygen consumption at anaerobic 
threshold (ml/kg/min) 
11.5±2.9 12.8±2.2 0.39 11.3 
Rate of perceived exertion 16±2.4 17±2.3 0.22 6.3 
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Table 3. Blood biomarkers and quality of life (mean ± SD) following 12 weeks of Active-at-
Home-HF  
 Pre Intervention Post Intervention P Value % Change 
Cholesterol 
(mmol/L) 
4.0±0.9 3.9±0.9 0.59 2.5 
Triglyceride 
(mmol/L) 
1.5±0.7 1.8±0.9 0.45 20 
HDL (mmol/L) 1.2±0.3 1.1±0.3 0.67 8.3 
LDL (mmol/L) 2.1±0.7 1.9±0.7 0.46 9.5 
HbA1c (mmol/mol) 49.2±17.3 47.5±12 0.77 3.5 
FBG (mmol/L) 6.2±2.9 7.0±3.8 0.56 12.9 
NT proBNP (pg/ml) 823±1085 876±1114 0.89 6.4 
Renal function eGFR 65.4±18.6 61.4±17.4 0.61 6.1 
QoL 26±18 22±23 0.50 15.4 
HDL, high density lipoprotein; LDL, low density lipoprotein; HBA1c, glycated 
Haemoglobin; FBG, fasting blood glucose; NT proBNP, N-terminal brain natriuretic 
peptide; QoL, quality of life; eGFR, glomerular filtration rate 
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 Figure 1 Flow diagram showing patient screening and recruitment into Active-at-home HF 
intervention   
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 Figure 2. Mean (+SD) number of steps achieved at baseline and at the end of weeks 3 and 12 
of physical activity intervention 
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 Figure 3. Relationship between number of steps and peak oxygen consumption pre and post 
intervention. 
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